A RETROSPECTIVE STUDY OF VISUAL OUTCOME OF PATIENTS WITH PROGRESSIVE KERATOCONUS AFTER CORNEAL COLLAGEN CROSSLINKING
Tara Mahmood Hassana and Ballga Barzan Ahmed b
Background
Corneal collagen cross-linking is a new treatment modality aimed at increasing the biomechanical stability of the cornea through the application of riboflavin and UVA-induced collagen cross-linking it seems to be possible to stop the progression of keratoconus (a progressive, non-inflammatory corneal thinning disorder).
Objectives
To assess the effectiveness of corneal collagen cross-linking in stabilizing progression of keratoconus and visual effects in patients with progressive disease.
Patients and Methods
Fifty nine eyes of thirty-five patients with progressive keratoconus (19 females and 16 males) who underwent corneal collagen crosslinking between Dec. 2013 and Sep. 2014 were included in a retrospective non-controlled experimental study. The data collected in Tooe Maleek private hospital and Shahid-Aso Eye Teaching Hospital, in which recorded pre-procedure uncorrected, and best spectacle-corrected visual acuity using Snellen acuity chart-decimal notation, autorefraction (by autorefractometer) and topography findings (CCT and mean K-reading using OCULUS-PENTACAM) were taken and patients examined after the procedure in a period between 6-12 months and then pre and post crosslinking findings were compared. The data were collected between January to July 2015.

